CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Alvogen Pharma US, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Alvogen Pharma US, Inc.
10 Bloomfield Ave
Phone: 973-796-3400p:973-796-3400 Pine Brook, NJ  07058  United States Fax: 973-796-3439f:973-796-3439

This company was Merged or Acquired on 6/22/2015.
Acquired by an investor consortium led by CVC Capital Partners Ltd.

Business Summary
Alvogen Pharma US, Inc. is a multinational, privately-owned pharmaceuticals company, focused on complex generic pharmaceutical products. The Company's lines of business include generic sales and marketing, product development, contract manufacturing and contract research. The Company's product portfolio consists of a broad range of molecules for the treatment of conditions in the areas of oncology, cardiology, respiratory, neurology and gastroenterology in addition to a portfolio of biosimilars and OTC products. Its product formulations include solid oral dosage, soft gelatin capsules, modified release tablets, transdermals, creams, ointments, and injectables. The Company is a subsidiary of Alvogen Lux Holdings Sarl ("LuxCo"). It comprises the US generic pharmaceuticals and contract manufacturing operations of LuxCo. The Company is 40% owned by Aztiq SICAR investment fund and 60% owned by Al Maseera (a Saudi family-owned company), GMS Holdings (a Jordanian family-owned company) and AFI Partners.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
---Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
--Yes--YesYes

Industries
SIC Code Description
2834 Pharmaceutical preparations

Subsidiaries
Business Name Address City State/Province Country
ALVOGEN PHARMA US, INC.

General Information
Fax Number: 973-796-3439
Email Address: info@alvogen.com


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, November 15, 2019